Citations for
1CFP, MPO
Myeloperoxidase directs properdin-mediated complement activation.
O'Flynn J, Dixon KO, Faber Krol MC, Daha MR, van Kooten C.
J Innate Immun 6(4):417-25. doi: 10.1159/000356980. Epub 2013 Dec 20. 2014
2CFP, PFD
Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies.
van den Bogaard R, Fijen CA, Schipper MG, de Galan L, Kuijper EJ, Mannens MM.
Eur J Hum Genet 8(7):513-8. 2000
3CFP
Sequence-based analysis of properdin deficiency : identification of point mutations in two phenotypic forms of an X-linked immunodeficiency.
Westberg J, et al.
Genomics 29 : 1-8. 1995
4CFP
Further studies on conserved loci in Xp11.22-p11.21.
Boyd Y, et al.
Cytogenet Cell Genet 64 : 173. 1993
5CFP
Characterization of the human properdin gene.
Nolan KF, et al.
Biochem J 287 : 291-297. 1992
6CFP
Genetic and physical mapping around the retinitis pigmentosa (RP2) locus in Xp11.23.
Coleman MP, et al.
(HGM11) Cytogenet Cell Genet 58 : 2060. 1991
7CFP
Genetic and physical mapping around the properdin P gene.
Coleman MP, et al.
Genomics 11 : 991-996. 1991
8CFP, PFD
Localization of the properdin structural locus to Xp11.23-Xp21.1.
Goundis D, Holt SM, Boyd Y, Reid KB.
Genomics 5 : 56-60. 1989
9CFP
Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs.
Goundis D, et al.
Nature 335 : 82-85. 1988